ADORA1 and central nervous system cancer: The immunohistochemical analysis revealed an increase in the proportion of ki67-positive cells in glioma tissues within the ADORA1 overexpression group, while the ki67 positivity rate diminished following KNG1 overexpression (Figure 6E, F).